Results 181 to 189 of about 681,545 (189)

ALTERATIONS IN CHOLINERGIC AND PURINERGIC SIGNALING IN A MODEL OF THE OBSTRUCTED BLADDER

Journal of Urology, 2001
R J Morgan, D P Mikhailidis
exaly  

Exclusive patent, know-how, process and technology license, including improvements, to develop, use, manufacture, register, market, sell, package, label and sublicense ophthalmic formulations that contain P1,P4-Di(Uridine 5'-Tetraphosphate), based on purinergic receptor agonists, to treat ocular surface diseases in humans, including dry eye.

2000
openaire   +1 more source

Top bar navigation

Frontiers in Immunology, 2018
Xu Wang, Deyu Chen
exaly  

Exclusive patent, know-how, process, technology and trade secret license, including improvements, to develop, use, manufacture, market, sell, package, label and sublicense ophthalmic formulations containing the P1,P4-Di uridine 5'-tetraphosphate compound, based on purinergic receptor agonists, to treat ocular surface diseases in humans, including dry eye.

2000
openaire   +1 more source

Therapeutic potential of purinergic signalling for diseases of the urinary tract

BJU International, 2011

exaly  

Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics

Journal of Advanced Research
Huanqiu Li, Yifan Zhu, Shige Shen
exaly  

The impact of commercially available purinergic ligands on purinergic signalling research

Purinergic Signalling, 2011
exaly  

Purinergic P2 receptors are under negative control of P1 receptors in the regulation of renal hemodynamics in diabetic rats

2016
openaire  

Cytokine storm in human monkeypox: A possible involvement of purinergic signaling

Cytokine
Margarete Bagatini, Júlia Leão Batista Simões, Gilnei Bruno Da Silva   +2 more
exaly